Key Points: In today’s Recommendations for Industry, we have a short discussion on increasing influenza cases around the US (as you’ll see in the Influenza Update below) and also how COVID-19 is trending across the country. Read more below. The...

Key Points: In today’s Recommendations for Industry, we discuss the continued decline of COVID-19 cases and hospitalizations in the US and what Europe’s trends may mean here. Read more below. Senate votes to overturn mask mandate on airplanes, transit. The...

Key Points: In today’s Recommendations for Industry, we discuss the ongoing need for symptom monitoring. Read more below. The CDC will extend its mask-use on public transportation order until April 18, 2022. It does not seem that the U.S. will...

Key Points: In today’s Recommendations for Industry, we discuss a return to normal. Read more below. In a recent paper published in JAMA Neurology, CIDRAP cites that in patients over 60 years old who had developed severe illness, “cognitive impairment”...

Key Points: In today’s Recommendations for Industry, we discuss combatting infectious diseases in the world’s “next normal.” Read more below. The pandemic global death rate has now exceeded 6 million (NYT). 24 U.S. experts have co-authored a new roadmap as...

Key Points: In today’s Recommendations for Industry, we discuss the impact of the national COVID plans on workforce decision-making. Read more below. White House Releases National COVID-19 Preparedness Plan. On Wednesday, the U.S. government released the National COVID-19 Preparedness Plan laying...

Key Points: In today’s Recommendations for Industry, we discuss CDC’s new masking guidance and the utilization of the County-Searchable Tool. Read more below. A recent CDC study has found that about 43% of individuals (>140 million) in the U.S. have...

Key Points: In today’s Recommendations for Industry, we discuss TAG’s weekly COVID matrix and its indicators for endemic vs. pandemic and related masking requirements. Read more below. A new, two-dose COVID vaccine showed 100% efficacy against severe disease. Two doses...

Key Points: In today’s Recommendations for Industry, we discuss how businesses can assess risk when considering lifting of COVID protections, including masking.  Read more below. US COVID cases, hospitalizations continue steady decline. Average daily COVID-19 cases and hospitalizations are continuing...

Key Points: In today’s Recommendations for Industry, we discuss the question: When can our business reduce or rescind our masking requirements? Read more below. Further decline in global COVID cases as deaths stabilize. COVID-19 cases across the globe declined last...